Response to ‘Eruptive keratoacanthomas associated with dupilumab therapy’

Case of a patient developing multiple rashes of squamous cell carcinoma 6 weeks after the introduction of dupilumab due to atopic eczema.[Image: see text]

Detalles Bibliográficos
Autores principales: Patchinsky, Alexandra, Kalita, Victoria, Muller, Philippe, Petitpain, Nadine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233080/
https://www.ncbi.nlm.nih.gov/pubmed/37275419
http://dx.doi.org/10.1002/ski2.197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233080/
https://www.ncbi.nlm.nih.gov/pubmed/37275419
http://dx.doi.org/10.1002/ski2.197

Ejemplares similares